Biovica International AB (BIOVIC.B) Stock Overview

Biovica International AB (publ), a biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum TKa, a biomarker assay that measures thymidine kinase activity, which reflects tumor cell proliferation. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.

BIOVIC.B Stock Information

Symbol

BIOVIC.B

Address

Dag HammarskjOelds vAeg 54BUppsala, 752 37Sweden

Founded

Trading hours

Website

https://www.biovica.com

Country

🇸🇪 Sweden

Phone Number

46 1 84 44 48 30

Biovica International AB (BIOVIC.B) Price Chart

Biovica International AB Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.24511846575449917	N/A
Market Cap	$8.45M	N/A
Shares Outstanding	34.46M	19.84%
Employees	37.00	N/A
Shareholder Equity	138.64M	11.72%

Valuation	2023	Change
P/E Ratio	-0.08	N/A
P/S Ratio	25.46	N/A
P/B Ratio	0.06	N/A

Growth	2023	Change
Return on Equity	-0.0781	N/A

Earnings	2023	Change
Revenue	$331.79K	N/A
Earnings	-$10.83M	N/A
EPS	-3.20	N/A
Earnings Yield	-13.07	N/A
Gross Margin	1.36	N/A
Operating Margin	-32.78	N/A
Net income margin	-32.65	N/A

Financial Strength	2023	Change
Total Assets	$16.89M	N/A
Total Debt	$1.02M	N/A
Cash on Hand	$11.21M	N/A
Debt to Equity	0.0238	9.36%
Cash to Debt	$10.94	41.81%
Current Ratio	$5.08	-13.93%